{"schema_version":"secwatch.filing_event.v1","accession":"0001630627-26-000014","form_type":"8-K","ticker":"TMCI","cik":"0001630627","company_name":"TREACE MEDICAL CONCEPTS, INC.","filed_at":"2026-05-20T21:30:15+00:00","discovered_at":"2026-05-20T21:32:00.340437+00:00","generated_at":"2026-05-20T21:33:39.195817+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Treace Medical shareholders elect directors, approve exec compensation and auditor ratification","bullets":["Directors Lance Berry, Elizabeth Hanna, Jane Kiernan elected with over 30M votes each.","Advisory vote on executive compensation passed with 32.8M For vs 1.7M Against.","Ratification of Grant Thornton as auditor approved with 47.9M For vs 120.7K Against.","All three proposals passed at May 19, 2026 annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001630627-26-000014","json":"https://secwatch.observer/filing/0001630627-26-000014.json","markdown":"https://secwatch.observer/filing/0001630627-26-000014.md","text":"https://secwatch.observer/filing/0001630627-26-000014.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630627/000163062726000014/0001630627-26-000014-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630627/000163062726000014/tmci-20260519.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T21:33:39.195817+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"08b836058c17574c567a9e99aee75e43800286a2","claim":"TREACE MEDICAL CONCEPTS, INC. shareholders approved Election of three Class II directors at the 2026-05-19 meeting.","evidence_excerpt":"The stockholders elected, by the votes indicated below, the following nominees to the Company’s Board of Directors to serve as Class II directors for a three-year term of office expiring at the 2029 annual meeting of stockholders or until their respective successors have been duly elected and qualified: Name For Withheld Broker Non-Vote Lance A. Berry 33,804,407 820,723 13,516,432 Elizabeth S. Hanna 30,856,965 3,768,165 13,516,432 Jane E. Kiernan 33,587,226 1,037,904 13,516,432","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630627/000163062726000014/0001630627-26-000014-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-19"}],"fact_type":"shareholder_vote"},{"claim_id":"1d53f2f094b1d5ce11f77306cece244c98a48eae","claim":"TREACE MEDICAL CONCEPTS, INC. shareholders approved Advisory vote on executive compensation at the 2026-05-19 meeting.","evidence_excerpt":"By the vote stated below, the stockholders approved, on an advisory, non-binding basis, the compensation of the Company's named executive officers: For Against Abstain Broker Non-Vote 32,785,505 1,724,383 115,242 13,516,432","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630627/000163062726000014/0001630627-26-000014-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-19"}],"fact_type":"shareholder_vote"},{"claim_id":"268189a5b21abc3fd82d0b23f0310691c4877b60","claim":"TREACE MEDICAL CONCEPTS, INC. shareholders approved Ratification of appointment of Grant Thornton LLP as independent registered public accounting firm at the 2026-05-19 meeting.","evidence_excerpt":"By the vote stated below, the stockholders ratified the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026: For Against Abstain Broker Non-Vote 47,885,305 120,733 135,524 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630627/000163062726000014/0001630627-26-000014-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-19"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}